Polychromatic Flow Cytometric High-throughput Assay to Analyze the Innate Immune Response to Toll-like Receptor Stimulation

Overview

Journal J Immunol Methods

Publisher Elsevier

Specialties Allergy & Immunology
Pathology

Date 2008 Jun 21

PMID 18565537

Citations 31

Authors

Kirstin Jansen

Darren Blimkie

Jeff Furlong

Adeline Hajjar

Annie Rein-Weston

Juliet Crabtree

Brian Reikie

Christopher Wilson

Tobias Kollmann

Affiliations

Soon will be listed here.

Abstract

Polychromatic flow cytometry allows the capture of multidimensional data, providing the technical tool to assess complex immune responses. Interrogation of the adaptive T cell response to infection or vaccination already has benefited greatly from standardized protocols for polychromatic flow cytometric analysis. The innate immune system plays an important role in health and disease, and presents potentially important therapeutic and diagnostic modalities. We describe here a high-throughput polychromatic flow cytometry-based platform that enables the rapid interrogation and large scale screening of human blood antigen presenting cell responses to Toll-like receptor (TLR) ligands and other innate immune modulators. Using this assay, we found that for certain stimuli (e.g., TLR9 and TLR3 ligands), the general protocol for intracellular cytokine cytometry had to be significantly modified to allow response detection. Furthermore, high concentrations of TLR7/8 and TLR4 stimuli caused substantial changes in lineage markers, potentially confounding analysis if one were to use a conventional "lineage-negative" cocktail. The assay we developed is reproducible and has been used to show that a given individual's TLR response pattern is relatively stable over at least several months. This protocol is in strict compliance with published guidelines for polychromatic flow cytometry, provides a common platform for scientists to compare their results directly, and may be applicable to the diagnostic evaluation of Toll-like receptor function and the rapid screening of promising therapeutic innate immune modulators.

Citing Articles

Immune profiling reveals umbilical cord blood mononuclear cells from South India display an IL-8 dominant, CXCL-10 deficient polyfunctional monocyte response to pathogen-associated molecular patterns that is distinct from adult blood cells.

Adiga V, Bindhu H, Ahmed A, Chetan Kumar N, Tripathi H, DSouza G Clin Exp Immunol. 2024; 217(3):263-278.

PMID: 38695079 PMC: 11310697. DOI: 10.1093/cei/uxae034.

Cord blood sphingolipids are associated with atopic dermatitis and wheeze in the first year of life.

Hoji A, Kumar R, Gern J, Bendixsen C, Seroogy C, Cook-Mills J J Allergy Clin Immunol Glob. 2022; 1(3):162-171.

PMID: 36117517 PMC: 9479978. DOI: 10.1016/j.jacig.2022.03.002.

Transcriptomic profile investigations highlight a putative role for NUDT16 in sepsis.

Huang S, Rinchai D, Toufiq M, Kabeer B, Roelands J, Hendrickx W J Cell Mol Med. 2022; 26(5):1714-1721.

PMID: 35174610 PMC: 8899167. DOI: 10.1111/jcmm.17240.

Transcriptome and Literature Mining Highlight the Differential Expression of ERLIN1 in Immune Cells during Sepsis.

Huang S, Toufiq M, Saraiva L, van Panhuys N, Chaussabel D, Garand M Biology (Basel). 2021; 10(8).

PMID: 34439987 PMC: 8389572. DOI: 10.3390/biology10080755.

Respiratory health, allergies, and the farm environment: design, methods and enrollment in the observational Wisconsin Infant Study Cohort (WISC): a research proposal.

Seroogy C, VanWormer J, Olson B, Evans M, Johnson T, Cole D BMC Res Notes. 2019; 12(1):423.

PMID: 31311588 PMC: 6636141. DOI: 10.1186/s13104-019-4448-0.

References

Ivanov S, Dragoi A, Wang X, Dallacosta C, Louten J, Musco G . A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood. 2007; 110(6):1970-81. PMC: 1976374. DOI: 10.1182/blood-2006-09-044776. View

Karin M, Lawrence T, Nizet V . Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell. 2006; 124(4):823-35. DOI: 10.1016/j.cell.2006.02.016. View

Marshak-Rothstein A . Toll-like receptors in systemic autoimmune disease. Nat Rev Immunol. 2006; 6(11):823-35. PMC: 7097510. DOI: 10.1038/nri1957. View

Maecker H, Rinfret A, DSouza P, Darden J, Roig E, Landry C . Standardization of cytokine flow cytometry assays. BMC Immunol. 2005; 6:13. PMC: 1184077. DOI: 10.1186/1471-2172-6-13. View

Tesar B, Goldstein D . Toll-like receptors and their role in transplantation. Front Biosci. 2007; 12:4221-38. DOI: 10.2741/2382. View

Maecker H, Trotter J . Flow cytometry controls, instrument setup, and the determination of positivity. Cytometry A. 2006; 69(9):1037-42. DOI: 10.1002/cyto.a.20333. View

Turvey S, Hawn T . Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin Immunol. 2006; 120(1):1-9. DOI: 10.1016/j.clim.2006.02.003. View

Horton H, Thomas E, Stucky J, Frank I, Moodie Z, Huang Y . Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination. J Immunol Methods. 2007; 323(1):39-54. PMC: 2683732. DOI: 10.1016/j.jim.2007.03.002. View

Amati L, Pepe M, Passeri M, Mastronardi M, Jirillo E, Covelli V . Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. Curr Pharm Des. 2006; 12(32):4247-54. DOI: 10.2174/138161206778743583. View

10.

Phillips D, League S, Weinstein P, Hooper W . Interference in microsphere flow cytometric multiplexed immunoassays for human cytokine estimation. Cytokine. 2007; 36(3-4):180-8. DOI: 10.1016/j.cyto.2006.12.002. View

11.

Kanzler H, Barrat F, Hessel E, Coffman R . Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med. 2007; 13(5):552-9. DOI: 10.1038/nm1589. View

12.

Vuckovic S, Gardiner D, Field K, Chapman G, Khalil D, Gill D . Monitoring dendritic cells in clinical practice using a new whole blood single-platform TruCOUNT assay. J Immunol Methods. 2004; 284(1-2):73-87. DOI: 10.1016/j.jim.2003.10.006. View

13.

Perfetto S, Chattopadhyay P, Roederer M . Seventeen-colour flow cytometry: unravelling the immune system. Nat Rev Immunol. 2004; 4(8):648-55. DOI: 10.1038/nri1416. View

14.

Goldman M . Translational mini-review series on Toll-like receptors: Toll-like receptor ligands as novel pharmaceuticals for allergic disorders. Clin Exp Immunol. 2007; 147(2):208-16. PMC: 1810467. DOI: 10.1111/j.1365-2249.2006.03296.x. View

15.

Takahashi H, Morichika T, Iwagaki H, Tamura R, Kubo S, Yoshino T . Histamine downregulates CD14 expression via H2 receptors on human monocytes. Clin Immunol. 2003; 108(3):274-81. DOI: 10.1016/s1521-6616(03)00140-2. View

16.

Lamoreaux L, Roederer M, Koup R . Intracellular cytokine optimization and standard operating procedure. Nat Protoc. 2007; 1(3):1507-16. DOI: 10.1038/nprot.2006.268. View

17.

Levy O . Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol. 2007; 7(5):379-90. DOI: 10.1038/nri2075. View

18.

Deering R, Orange J . Development of a clinical assay to evaluate toll-like receptor function. Clin Vaccine Immunol. 2006; 13(1):68-76. PMC: 1356616. DOI: 10.1128/CVI.13.1.68-76.2006. View

19.

Steinman R, Hemmi H . Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol. 2006; 311:17-58. DOI: 10.1007/3-540-32636-7_2. View

20.

Kim Y, Brinkmann M, Paquet M, Ploegh H . UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature. 2008; 452(7184):234-8. DOI: 10.1038/nature06726. View